Medical Consent Form (Singapore)

A Medical Consent Form in Singapore records the consent or release given and the scope of what the party agrees to.

The doctrine of informed consent in Singapore was authoritatively established by the Court of Appeal in Hii Chii Kok v Ooi Peng Jin London Lucien [2017] SGCA 38, which adopted the Montgomery test (from the UK Supreme Court decision in Montgomery v Lanarkshire Health Board [2015] UKSC 11) replacing the earlier Bolam-Bolitho standard. Under the Montgomery test adopted in Singapore, a medical practitioner must disclose to the patient all material risks associated with a proposed treatment — a risk being material if a reasonable person in the patient's position would be likely to attach significance to it, or if the practitioner is or should reasonably be aware that the particular patient would attach significance to it.

The PDPA governs the collection, use, and disclosure of patient personal data and health information by healthcare providers. Under Section 13 of the PDPA, healthcare providers must obtain consent before collecting personal data (including medical records, diagnostic results, and treatment information) and must use such data only for purposes that the patient has consented to. The Health Information Bill (currently under development by the Ministry of Health) is expected to introduce sector-specific data protection rules for healthcare, complementing the PDPA framework. Healthcare institutions licensed under the Healthcare Services Act 2020 (HSA 2020) — which replaced the Private Hospitals and Medical Clinics Act — must maintain proper patient consent records as part of their licensing conditions.

Related documents include the Data Collection Consent Form addressing broader PDPA consent for personal data processing, the Research Consent Form for clinical research subject consent under the Human Biomedical Research Act 2015 (HBRA, Act No. 29 of 2015), and the Guardianship Application for patients lacking mental capacity under the Mental Capacity Act (Cap. 177A).

The common-law doctrine of informed consent affirmed by the Court of Appeal in Hii Chii Kok v Ooi Peng Jin London Lucien [2017] SGCA 38, together with the SMC Ethical Code and Ethical Guidelines (ECEG) 2016 and the Healthcare Services Act 2020, governs the requirements applicable to this document in Singapore, requiring disclosure of material risks, benefits, and alternatives and the patient's voluntary agreement. The Personal Data Protection Act 2012 (PDPA, No. 26 of 2012) applies to any personal data collected, used, or disclosed in connection with this document, and the Personal Data Protection Commission (PDPC) oversees compliance with the PDPA's consent, purpose limitation, and data protection obligations.

A Medical Consent Form in Singapore is required whenever a healthcare provider proposes to perform a medical procedure, surgical operation, diagnostic examination, or treatment on a patient, fulfilling the informed consent obligations established by the Singapore Medical Council (SMC) Ethical Code and Ethical Guidelines (ECEG) 2016 and the common law duty of disclosure affirmed in Hii Chii Kok v Ooi Peng Jin London Lucien [2017] SGCA 38.

Patients undergoing surgical procedures at hospitals, ambulatory surgical centres, or day surgery facilities licensed under the Healthcare Services Act 2020 (HSA 2020) must sign a Medical Consent Form before the procedure. The Ministry of Health (MOH) licensing conditions require healthcare institutions to implement consent protocols documenting the patient's agreement to the proposed surgery, acknowledgment of material risks and complications, and understanding of available alternatives. Surgical consent forms are reviewed during MOH compliance inspections and accreditation surveys conducted by the Joint Commission International (JCI) or the Singapore Healthcare Accreditation Council.

Patients receiving anaesthesia — whether general anaesthesia, regional anaesthesia, or procedural sedation — require a separate anaesthesia consent form or a combined surgical and anaesthesia consent form disclosing anaesthesia-specific risks (adverse drug reactions, respiratory complications, nerve injury) as mandated by the SMC ECEG 2016 and the Singapore Society of Anaesthesiologists (SSA) practice guidelines.

Patients participating in clinical trials or biomedical research must provide informed consent under the Human Biomedical Research Act 2015 (HBRA), which requires Institutional Review Board (IRB) approval for all human biomedical research and prescribes specific consent requirements including the right to withdraw at any time without penalty. The Health Sciences Authority (HSA) regulates clinical trials of therapeutic products under the Health Products Act (Cap. 122D) and the Health Products (Clinical Trials) Regulations 2016.

Patients lacking mental capacity — due to cognitive impairment, unconsciousness, or mental illness — may require consent from a court-appointed deputy or donee of a Lasting Power of Attorney (LPA) under the Mental Capacity Act (Cap. 177A). Healthcare providers treating incapacitated patients without a deputy or LPA must act in the patient's best interests under the common law doctrine of necessity and document the clinical rationale for proceeding without patient consent.

Aesthetic and cosmetic procedure clinics — offering treatments such as liposuction, rhinoplasty, botulinum toxin injections, and dermal fillers — must obtain specific informed consent addressing the elective nature of the procedure, realistic outcome expectations, and the patient's right to a cooling-off period. The SMC Guidelines on Aesthetic Practices (2021) require enhanced disclosure for aesthetic procedures, including photographic documentation of pre-treatment appearance and written acknowledgment of potential complications.

A Singapore Medical Consent Form compliant with the SMC Ethical Code and Ethical Guidelines (ECEG) 2016, the Healthcare Services Act 2020, and the Personal Data Protection Act 2012 (PDPA) must include the following elements to create valid informed consent and protect both the patient and the healthcare provider.

Patient identification must include the patient's full legal name, NRIC number or passport number, date of birth, gender, and contact details. For patients under 21 years of age, the name and relationship of the parent or legal guardian providing consent must be recorded. For patients lacking mental capacity, the name and authority of the court-appointed deputy under the Mental Capacity Act (Cap. 177A) or the donee of a Lasting Power of Attorney (LPA) must be documented.

Procedure and treatment details must describe in clear, non-technical language the nature of the proposed procedure, treatment, or examination, the body part or system involved, the clinical indication (reason for the procedure), and whether the procedure is diagnostic, therapeutic, or elective. The SMC ECEG 2016 requires that the description be comprehensible to a layperson — medical jargon should be avoided or clearly explained.

Risks, benefits, and alternatives must disclose all material risks associated with the proposed procedure — applying the Montgomery test adopted by the Singapore Court of Appeal in Hii Chii Kok v Ooi Peng Jin London Lucien [2017] SGCA 38 — including common risks (occurring in more than 1% of cases), serious risks (including death, permanent disability, or significant complications), and risks specific to the patient's medical history or condition. The expected benefits of the procedure, the probability of success, and reasonable alternatives (including the option of no treatment and the consequences of declining the procedure) must be presented.

Doctor identification and confirmation must include the name and SMC registration number of the medical practitioner performing the procedure, the name and registration number of the anaesthetist (for procedures involving anaesthesia), and the practitioner's confirmation that they have explained the procedure, risks, benefits, and alternatives to the patient or the patient's authorised representative. The SMC ECEG 2016 requires the explaining doctor — not a nurse or administrative staff — to sign the consent form confirming that the explanation was given.

Consent declaration must include the patient's (or authorised representative's) written confirmation that they have received and understood the explanation of the procedure, its risks, benefits, and alternatives, have had the opportunity to ask questions, and voluntarily consent to the proposed procedure. The declaration should state that the patient understands they may withdraw consent at any time before the procedure commences.

Data protection notice under the PDPA must inform the patient that their personal data and health information will be collected, used, and disclosed by the healthcare provider for the purposes of treatment, medical records, billing, insurance claims, and any mandatory reporting obligations under the Infectious Diseases Act (Cap. 137) or other applicable statutes. The notice must identify the healthcare provider's Data Protection Officer (DPO) and provide contact details for data protection enquiries. The forms-legal.com Medical Consent Form template includes a PDPA-compliant data protection notice addressing the Personal Data Protection Commission's (PDPC) guidelines on healthcare sector data protection.

Witness signature should be obtained to attest that the patient signed the consent form voluntarily and appeared to understand the information provided. While Singapore law does not mandate a witness for medical consent forms, the SMC ECEG 2016 recommends obtaining a witness signature — particularly for high-risk procedures, procedures involving vulnerable patients, or situations where the patient's capacity to consent may be questioned.